The effect of Ursodeoxycholic Acid on neonatal jaundice

Phase 3

Recruiting

• Conditions: eonatal indirect hyperbilirubinemia.; Neonatal jaundice from other specified causes; P59.8

• Registration Number: IRCT20190604043813N2
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 April 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Exclusive breastfeeding,
Total bilirubin levels above 14 mg / dL and below 20 mg / dL,
Direct bilirubin levels below 2 mg / dL.
Age above 1 day
Glucose 6 phosphate dehydrogenase deficiency
Parent consent

Exclusion Criteria

Infection and septicemia
Uunderlying disease such as heart and liver disease
The diabetic mother
Rh incompatibility

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Total bilirubin. Timepoint: Every 24 hours until total bilirubin fall bellow 10 mg/dl. Method of measurement: Total bilirubin is measured by the diazo method.

Secondary Outcome Measures

Name	Time	Method
Median admission time. Timepoint: Once. Method of measurement: The number of hospitalization days.